Research interests include CAR-T cell therapy research, Cancer therapeutics and mechanisms, Sleep and Wakefulness Research, and Biosimilars and Bioanalytical Methods.
New England Journal of Medicine2022cited by 381position: middledoi
Phase I First-in-Class Trial of MCARH109, a G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D) Targeted CAR T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma